Rachel Hatton, Pharm.D.
Dr. Rachel Hatton, from Sugar Land, TX, received her Doctor of Pharmacy degree from Nova Southeastern University in 2019. She completed her PGY-1 residency at Orlando Health in 2020. As a PGY-2 oncology pharmacy resident at Orlando Health Cancer Center, Rachel will participate in inpatient and outpatient care as well as research at the institution. Her research project will evaluate the incidence of hypertension associated with bevacizumab use. She will also complete an MUE looking hepatitis B screening in patients being treated with anti-CD20 agents and present a continuing education seminar on acute graft-versus-host disease. Following completion of her oncology pharmacy residency, Rachel intends to pursue a career as a clinical specialist in oncology.
Email: [email protected]